Basic and translational oncology research centers
Strengthen efficacy and safety evidence using relevant preclinical models and translational data.
Offer overview
What this offer helps you achieve
Strengthen efficacy and safety evidence using relevant preclinical models and translational data.
Scientific and technical scope
The French National Cancer Institute has introduced a competitive policy of labelling integrated cancer research sites (SiRIC). Their objective is to offer new operational conditions for translational research in cancerology, in order to optimize and accelerate the production of new knowledge and to promote its dissemination and application in the treatment of cancers. Cancer Research in multiple dimensions to accelerate PrEcision Medicine Pr Pierre Laurent-Puig Cancer United Research Associating Medicine, University & Society Pr Marc Sanson From Inflammation to Tumor - Prevent, Intercept, CurePr Valérie Paradis
Capabilities mobilised
Therapeutic areasTherapeutic target discoveryValidation using preclinical modelsBiotesting
Application fields
Oncology
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
